In September of 2013, Bryce’s parents learned that their adorable, newborn son had a life-threatening disease. When he was diagnosed with sickle cell disease his parents, Adrienne and Bruce, were fearful for his future. Adrienne Gross knows from experience what it is like to have sickle cell disease, as her mother helped her while she was going through treatment. Both of Bryce’s parents have the sickle cell trait, which meant they had a 1-in-4 chance of having a child with the disease.
“I was just in panic mode, in shock,” said Adrienne. Then they got the call from St. Jude Children’s Research Hospital where Bryce was offered ongoing care for sickle cell disease. At St. Jude, everything changed.
From our first research grant in 1958 to pioneering the use of hydroxyurea in pediatric sickle cell patients, St. Jude has been committed to finding a cure for sickle cell disease. We have one of the largest sickle cell disease programs in the country, and one of our patients was the first person in the world to be cured of sickle cell disease through a bone marrow transplant.
Today, we’re building on that legacy by expanding our sickle cell program from treating the disease to searching for cures.